Cleared Traditional

K132611 - MICROTABLE SYSTEM

K132611 is an FDA 510(k) clearance for MICROTABLE SYSTEM, manufactured by Fred Haer Company, Inc.. The device is a Class 2 Neurology device with product code HAW cleared through the Traditional 510(k) pathway after a 198-day FDA review.

K132611 · Fred Haer Company, Inc. · Neurology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Mar 2014
Decision
198d
Days
Class 2
Risk

K132611 is an FDA 510(k) clearance for the MICROTABLE SYSTEM. Classified as Neurological Stereotaxic Instrument (product code HAW), Class II - Special Controls.

Submitted by Fred Haer Company, Inc. (Bowdoin, US). The FDA issued a Cleared decision on March 6, 2014 after a review of 198 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4560 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K132611

510(k) Number K132611 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 20, 2013
Decision Date March 06, 2014
Days to Decision 198 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
49d slower than avg
Panel avg: 149d · This submission: 198d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HAW Device Classification - Class 2, Special Controls

Product Code HAW Neurological Stereotaxic Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HAW Neurological Stereotaxic Instrument

All 406
Devices cleared under the same product code (HAW) and FDA review panel - the closest regulatory comparables to K132611.
STEALTHSTATION S7 / I7 / FUSION NAVIGATION SYSTEMS, AXIEM NAVIGATION SYSTEM
K133444 · Medtronic Navigation, Inc. · Jul 2014
STRYKER KWIC NEEDLE
K140868 · Orthovita, Inc. · Jun 2014
NEUROMATE FRAMELESS GEN II
K132755 · Renishaw Mayfield Sarl · Apr 2014
CRANIAL MAP NEURO
K131214 · Stryker Corporate · Oct 2013
STRYKER NAV3I PLATFORM
K130874 · Stryker Corporate · Sep 2013
QUADCUT
K130608 · Medtronic Navigation, Inc. · Aug 2013
K132611 · MICROTABLE SYSTEM
Download PDF FDA Summary Fred Haer Company, In…